Abstract:Abstract Our previous work has shown a synergistic tumoricidal efficacy of combining the hexokinase (HK) inhibitor 2‐deoxyglucose (2‐DG) and the autophagy inhibitor chloroquine (CQ) through intraperitoneal injections on HK2‐addicted prostate cancers in animal models. The pharmacokinetic (PK) behaviors of these oral drugs after simultaneous oral administration have not been reported. We developed high‐performance liquid chromatography–tandem mass spectrometry (HPLC‐MS–MS) analytical methods for 2‐DG and the clinically favored drug hydroxychloroquine (HCQ) for sera samples. Using a jugular vein‐cannulated male rat model with serial blood collection before and after a single gavage dose of each drug alone or in combination, we examined their PK metrics for drug–drug interactions. The data demonstrated a rapid and complete separation of 2‐DG from common monosaccharides by HPLC‐MS–MS multi‐reaction monitoring. Application of the HPLC‐MS–MS 2‐DG and HCQ methods to sera samples of nine rats showed a peak time ( T max ) for 2‐DG of 0.5 h after 2‐DG alone or with HCQ and identical post‐peak half‐life of approximately 1 h. With a seemingly bi‐modal time course for HCQ, the T max for HCQ alone (1.2 h) was faster than that for the combination (2 h; p = .017). After combination dosing, the peak concentration ( C max ) and area under the curve (AUC 0‐4h ) of 2‐DG were decreased by 53.8% ( p = .0004) and 53.7% ( p = .0001), whereas AUC 0‐8h for HCQ was decreased by 30.8% ( p = .0279) from the respective single dosing. Without changing the mean residence time (MRT 0‐∞ ) of each drug, the combination affected the apparent volume of distribution ( V d ) and clearance (CL) of 2‐DG, and CL for HCQ without affecting its V d . We observed significant negative PK interactions, probably at the intestinal absorption level, between 2‐DG and HCQ taken simultaneously by mouth. Future optimization efforts are warranted for their combination regimen for clinical translation.

Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans

Recipe Analysis of Digoxin in Outpatients from a Perspective of Pharmacokinetic Interaction

Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model

Co-Administration of a Water-Soluble Polymer Increases the Usefulness of Cyclodextrins in Solid Oral Dosage Forms

Enhanced oral bioavailability of all-trans-retinoic acid by 2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique

[Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].

2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review

Preparation of inclusion complex of daidzein and hydropropyl-β- cyclodextrin

Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers

Effects of Hydroxypropyl-beta-cyclodextrin ( HPCD ) on the Interaction of 1-Hydroxypyrene with Bovine Serum Albumin

Study on Pharmacokinetics and Bioavailability of Potassium Dehydroandrographolide Succinate Hollow Suppositories in Rabbits

Preparation of Hydrocortisone-Hydroxypropyl-β-cyclodextrin Inclusion Complex (Hc-Hp-β-cd)

Absorption of Irisquinone-Hydroxypropyl-β-cyclodextrin Inclusion Complex in Intestinal and Its Pharmacokinetics in Rats

Effects of Hydroxypropyl-β-cyclodextrin(HPCD) on the Interaction of 1-Hydroxypyrene with Bovine Serum Albumin?

Effects of Gatifloxacin on plasma digoxin levels in rabbits

2‐Deoxyglucose and hydroxychloroquine HPLC‐MS–MS analytical methods and pharmacokinetic interactions after oral co‐administration in male rats

Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin

Pharmacokinetics and pharmacodynamics of cyclodextrin-based oral drug delivery formulations for disease therapy

Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated DSS-induced colitis in mice

Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats

Effect of Hydropropyl-β-Cyclodextrin on Solubility of Prazosin Hydrochloride